Meeting Banner
Abstract #1205

Characterization of a Novel Gadolinium-Based High Molecular Weight Polymer as an Intravascular MR Contrast Agent

Anne Kirchherr1, Danielle Franke1, Detlef Stiller2, Andreas Briel1

1nanoPET Pharma GmbH, Berlin, Germany; 2In-Vivo Imaging, Target Discovery Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany

In the present work a blood pool contrast agent (CA) composed of Gd-DTPA conjugated to a biodegradable polymer was synthesized and characterized. The CA showed high contrast efficiency with 2 - 3 times higher relaxivities compared to conventional contrast agents. in vivo experiments in mice showed that the CA remained within the vascular system for a prolonged period of time compared to Gd-DTPA and that it was cleared from the blood through renal excretion with a half-life of 1.9 h. The novel contrast agent can be of use in magnetic resonance angiography and in studies of renal structure and function.

Abstract PDF

Keywords

acquisition acts addition agent agents angiography assisting besides biodegradable blood body candidates characterization characterized chem clearance cleared clinical composed conjugated contrast detect determining discovery distribution dose drug efficiency elimination enables enhanced enhancement excellent excretion expert flash formulated function gadolinium half in vivo indicating inflamed injection intravenous larger life limitations longer longitudinal macromolecular macromolecules magma mice molecular molecule molecules mouse myocardium necrotic nonspecific novel objectives optimal overcome period permeation persistence polymer pool poor potentially prolonged properties rapid remained renal report resolution respectively retention scanner since solution spectrometer steady stiller structure studies surrounding synthesized system target tissue transverse tumorous tumors various vascular vessels vitro water wide